Form 4: Arteris CEO Charles Janac Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Arteris CEO Charles Janac sold a total of 26,801 shares of common stock in two transactions on December 17th and 18th, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- Arteris, Inc. CEO Charles Janac sold 14,180 shares of common stock on December 17, 2024, at a weighted average price of $10.0067 per share.
- On December 18, 2024, Mr. Janac sold an additional 12,621 shares at a weighted average price of $10.0744 per share.
- These transactions were executed under a 10b5-1 trading plan adopted on February 27, 2024.
- Following these sales, Mr. Janac directly owns 274,776 shares and indirectly owns 10,195,125 shares through Bayview Legacy, LLC, and 77,286 shares through the Charles and Lydia Janac Trust.
Sentiment
Score: 5
Explanation: The document is a routine SEC Form 4 filing for stock sales by an executive under a pre-arranged plan. It does not contain any information that would be considered significantly positive or negative.
Risks
- Sales by a company's CEO could be perceived negatively by the market, potentially impacting the stock price.
Industry Context
Executive stock sales are a common occurrence, and the use of a 10b5-1 trading plan is a standard practice to avoid accusations of insider trading. The sales are not necessarily indicative of the company's performance or future prospects.
Comparison to Industry Standards
- The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies to manage their personal finances and avoid accusations of insider trading.
- The reported sales are within the normal range of executive stock transactions and do not appear to be unusual compared to similar filings from other companies.
Stakeholder Impact
- The stock sales by the CEO could potentially cause a minor negative reaction from shareholders, although the use of a 10b5-1 plan mitigates this risk.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date the 10b5-1 trading plan was adopted by the Reporting Person. |
| 12/17/2024 | Date of the first reported stock sale by Charles Janac. |
| 12/18/2024 | Date of the second reported stock sale by Charles Janac. |
| 12/19/2024 | Date the Form 4 was signed. |
Keywords
Arteris, Charles Janac, insider trading, 10b5-1 plan, stock sale, executive, share sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.